Apr 15
|
Shareholders in LivaNova (NASDAQ:LIVN) have lost 34%, as stock drops 3.1% this past week
|
Mar 21
|
LivaNova to Announce First-Quarter 2024 Results
|
Mar 21
|
LivaNova (LIVN) Soars 12.5%: Is Further Upside Left in the Stock?
|
Mar 20
|
LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea
|
Mar 19
|
Returns On Capital Signal Difficult Times Ahead For LivaNova (NASDAQ:LIVN)
|
Mar 6
|
LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029
|
Mar 4
|
LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior Notes
|
Mar 4
|
LivaNova to Present at the Barclays Global Healthcare Conference
|
Feb 5
|
LivaNova Announces Vladimir A. Makatsaria as CEO and Board Director
|
Jan 10
|
Livanova to close loss-making circulatory support business
|
Jan 8
|
LivaNova to Wind Down Advanced Circulatory Support Business Unit
|
Jan 4
|
LivaNova to Announce Fourth-Quarter and Full-Year 2023 Results
|
Dec 11
|
Is Now The Time To Look At Buying LivaNova PLC (NASDAQ:LIVN)?
|
Dec 5
|
Billionaire David Einhorn’s 10 Stock Picks with Huge Upside Potential
|
Nov 27
|
LivaNova warns cybersecurity incident disrupts systems, takes steps to limit impact
|
Nov 7
|
LivaNova (NASDAQ:LIVN) shareholders have endured a 58% loss from investing in the stock five years ago
|
Nov 2
|
LivaNova PLC (NASDAQ:LIVN) Q3 2023 Earnings Call Transcript
|
Sep 21
|
LivaNova Announces Marco Dolci, President of Cardiopulmonary, to Retire at the End of 2023
|
Sep 20
|
LivaNova to Announce Third-Quarter 2023 Results
|
Sep 5
|
LivaNova (LIVN) Advances Cardiopulmonary Wing With Essenz ILBM
|